Articles citing this paper
Carborane-Containing Hydroxyamidine Scaffolds as Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 (IDO1)
Christopher J. D. Austin A C , Michael Moir A C , Jan Kahlert A , Jason R. Smith B , Joanne F. Jamie B , Michael Kassiou A and Louis M. Rendina A D
+ Author Affiliations
- Author Affiliations
A School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
B Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW 2109, Australia.
C These authors contributed equally to the work in this paper.
D Corresponding author. Email: lou.rendina@sydney.edu.au
Australian Journal of Chemistry 68(12) 1866-1870 https://doi.org/10.1071/CH15489
Submitted: 11 August 2015 Accepted: 7 October 2015 Published: 9 November 2015
4 articles found in Crossref database.
Heme-containing enzymes and inhibitors for tryptophan metabolism
Yan Daojing,
Lin Ying-Wu, Tan Xiangshi
Metallomics. 2017 9(9). p.1230
New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies
Stockmann Philipp,
Gozzi Marta,
Kuhnert Robert,
Sárosi Menyhárt B., Hey-Hawkins Evamarie
Chemical Society Reviews. 2019 48(13). p.3497
Process Safety Considerations for the Supply of a High-Energy Oxadiazole IDO1-Selective Inhibitor
Martinot Theodore A.,
Ardolino Michael,
Chen Lu,
Lam Yu-hong,
Li Chaomin,
Maddess Matthew L.,
Muzzio Daniel,
Qi Ji,
Saurí Josep,
Song Zhiguo J.,
Tan Lushi,
Vickery Thomas,
Yin Jingjun, Zhao Ralph
Organic Process Research & Development. 2019 23(6). p.1178
Carboranes in drug discovery, chemical biology and molecular imaging
Marfavi Anita,
Kavianpour Poya, Rendina Louis M.
Nature Reviews Chemistry. 2022 6(7). p.486
